drugset / Trial / NCT00506623
Preoperative Chemoradiotherapy With Capecitabine Plus Irinotecan in Rectal Cancer
NaSingle-groupOpen-labelTreatment
Summary
This study is to evaluate the pathologic complete response rate to pre-operative concurrent chemoradiotherapy with capecitabine plus irinotecan in resectable rectal cancer
Timeline
- Start
- 2004-07
- Primary completion
- —
- Completion
- 2008-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Capecitabine | Small molecule | 1250 mg/m2 | Oral |
| Subject | Irinotecan | Small molecule | 40 mg/m2 | Intravenous |